Vir Biotechnology Inc (VIR)

EBITDA Margin

-88.37%

TTM · Period ending:

VIR logo

VIR EBITDA Margin

Latest reported-88.37%
VIR TTM EBITDA Margin (-1072.76% → -88.37%)
High-resolution chart · PNG

VIR ebitda margin history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Vir Biotechnology Inc EBITDA Margin — Trailing twelve months (TTM)
Period endingEBITDA Margin
-88.3688%
-688.677%
-665.6456%
-3,012.4852%
-2,900.7684%
-2,735.0511%
-685.6869%
-667.51%
-623.7382%
-722.4852%
-712.6201%
-545.2825%
-54.7454%
-63.1625%
52.5165%
65.984%
63.6308%
69.911%
41.3376%
-80.2939%
-155.0748%
-513.9826%
-369.8434%
-311.0323%
-261.8999%
-2,015.2345%
-2,092.8563%
-1,331.4155%
-1,057.5305%
-972.6345%
-1,072.7597%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.